Carestream Health’s groundbreaking Smart Noise Cancellation (SNC) technology has received FDA 510(k) Clearance for its dose reduction capability.

February 8, 2022 — Carestream Health’s groundbreaking Smart Noise Cancellation (SNC) technology has received FDA 510(k) Clearance for its dose reduction capability. The artificial intelligence (AI)-based feature allows a user to reduce dose without loss of image quality.* SNC provides improved diagnostic quality, preservation of fine detail and better contrast-to-noise ratio for images acquired at clinically nominal exposures.

“Carestream is continuously focused on reducing radiation dose without sacrificing image quality,” said Ron Muscosky, Worldwide Product Line Manager at Carestream. “The results of this reader study are another proof point of the quality of our high-performance image capture systems. This improved capability to optimize radiation dose will be especially valuable in neonatal and pediatric diagnostic imaging, where imaging at the lowest possible dose is crucial for young patients.”

SNC addresses a long-standing challenge in medical imaging of separating noise from an image. Traditional noise reduction introduces blurring, which degrades image sharpness and might remove important anatomical information. Conversely, the more an image is sharpened, the more noise may be enhanced. Carestream’s SNC overcomes this gridlock by isolating noise to produce images that are significantly clearer than with standard processing.

“Our AI-powered Smart Noise Cancellation gives radiologists another important tool to adjust the amount of noise cancellation and exposure to meet their desired imaging quality to aid their diagnosis,” Muscosky added.

When combined with SmartGrid software, Smart Noise Cancellation technology promises benefits in gridless imaging where the removal of scatter typically leads to an increase in noise appearance.

Smart Noise Cancellation software is available as an option with Carestream’s ImageView Software powered by Eclipse—the intelligent image-processing engine behind the company’s innovative imaging software. SNC is currently available on Carestream’s DRX-Evolution and DRX-Evolution Plus systems.

For more information: www.carestream.com

*These statements were verified using Carestream detectors in a reader study performed by board certified radiologists comparing pairwise images taken at nominal dose (CsI ISO 400 speed / GOS ISO 320 speed) and reduced dose (CsI ISO 800 speed / GOS ISO 500 speed) with SNC.


Related Content

News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
News | Computed Tomography (CT)

May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...

Time May 20, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
Subscribe Now